Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04903197
Title Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

Therapies

Lenalidomide + VAY736

VAY736

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU


No variant requirements are available.